Christoph Plass

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 250 publications

Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

Journal: Clinical epigenetics

Published: July 10, 2026

Continued remission maintained with decitabine monotherapy in an elderly patient with TP53 multi-hit acute myeloid leukemia relapsed after allogeneic transplantation.

Continued remission maintained with decitabine monotherapy in an elderly patient with TP53 multi-hit acute myeloid leukemia relapsed after allogeneic transplantation.

Journal: Haematologica

Published: May 05, 2026

Happy birthday IJC.

Happy birthday IJC.

Journal: International journal of cancer

Published: January 24, 2026

Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Journal: Blood advances

Published: December 09, 2025

Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Journal: Blood advances

Published: December 09, 2025

GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

Journal: Clinical epigenetics

Published: October 17, 2025

Principles of chromatin remodeling in cancer and translational perspectives.

Principles of chromatin remodeling in cancer and translational perspectives.

Journal: International journal of cancer

Published: October 14, 2025

Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programs.

Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programs.

Journal: Blood

Published: September 26, 2025

Multiomic profiling links L1 retrotransposition to genomic instability and ecDNA in bladder cancer.

Multiomic profiling links L1 retrotransposition to genomic instability and ecDNA in bladder cancer.

Journal: Nature communications

Published: August 27, 2025

Epigenetic dysregulation of IRF9 drives excessive interferon signaling in COPD.

Epigenetic dysregulation of IRF9 drives excessive interferon signaling in COPD.

Journal: EMBO molecular medicine

Published: August 12, 2025

ID3 deficiency alters chromatin accessibility at DSB sites and enhances vulnerability to HDAC inhibition.

ID3 deficiency alters chromatin accessibility at DSB sites and enhances vulnerability to HDAC inhibition.

Journal: International journal of cancer

Published: July 07, 2025

Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia.

Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia.

Journal: Blood cancer discovery

Published: July 02, 2025

Showing 1-12 of 250

Last Updated: 09/26/2026